The MASCC/ISOO mucositis guidelines update: Introduction to the first set of articles

Supportive Care in Cancer

Volumn 21, Issue 1, 2013, Pages 301-302

  Lalla, Rajesh V ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CYTOKINE; GROWTH FACTOR;

ADVERSE OUTCOME; CRYOTHERAPY; DRUG EFFECT; EDITORIAL; EVIDENCE BASED PRACTICE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSITIS; HEALTH CARE POLICY; HUMAN; LOW LEVEL LASER THERAPY; ORAL MUCOSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT PLANNING;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; MUCOSITIS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 84874105918     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1660-z     Document Type: Editorial

References (15)

1. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026-2046
2. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995-2025
3. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5):820-831
4. Keefe DM, Peterson DE, Schubert MM (2006) Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Support Care Cancer 14(6):492-498
5. Peterson DE, Keefe DM, Hutchins RD, Schubert MM (2006) Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer 14(6):499-504
6. Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS (2006) Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer 14(6):505-515
7. Anthony L, Bowen J, Garden A, Hewson I, Sonis S (2006) New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer 14(6):516-518
8. von Bultzingslowen I, Brennan MT, Spijkervet FK, Logan R, Stringer A, Raber-Durlacher JE, Keefe D (2006) Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 14(6):519-527
9. Barasch A, Elad S, Altman A, Damato K, Epstein J (2006) Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 14(6):528-532
10. Migliorati CA, Oberle-Edwards L, Schubert M (2006) The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Support Care Cancer 14(6):533-540
11. McGuire DB, Correa ME, Johnson J, Wienandts P (2006) The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14(6):541-547
12. Lalla RV, Schubert MM, Bensadoun RJ, Keefe D (2006) Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer 14(6):558-565
13. Bensadoun RJ, Schubert MM, Lalla RV, Keefe D (2006) Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 14(6):566-572
14. McGuire DB, Johnson J, Migliorati C (2006) Promulgation of guidelines for mucositis management: educating health care professionals and patients. Support Care Cancer 14(6):548-557
15. Brennan MT, von Bultzingslowen I, Schubert MM, Keefe D (2006) Alimentary mucositis: putting the guidelines into practice. Support Care Cancer 14(6):573-579